BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24716639)

  • 21. Clinical outcomes in a cohort of anti-hepatitis C virus-positive patients with significant barriers to treatment referred to a Norwegian outpatient clinic.
    Toresen KH; Salte IM; Skrede S; Nilsen RM; Leiva RA
    Scand J Gastroenterol; 2014 Apr; 49(4):465-72. PubMed ID: 24472091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy for hepatitis C virus infection increases survival of patients with pretreatment anemia.
    Mohanty A; Erqou S; McGinnis KA; Vanasse G; Freiberg MS; Sherman KE; Butt AA
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):741-7.e3. PubMed ID: 23376794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy.
    Backx M; Lewszuk A; White JR; Cole J; Sreedharan A; van Sanden S; Diels J; Lawson A; Neal KR; Wiselka MJ; Ito T; Irving WL
    J Viral Hepat; 2014 Mar; 21(3):208-15. PubMed ID: 24438682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic hepatitis C].
    Grammatikos G; Sarrazin C
    Dtsch Med Wochenschr; 2010 Dec; 135(50):2525-34; quiz 2535-8. PubMed ID: 21140330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].
    Kalayci R; Altindiş M; Gülamber G; Demirtürk N; Akcan Y; Demirdal T
    Mikrobiyol Bul; 2010 Apr; 44(2):237-43. PubMed ID: 20549958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Hepatitis C virus treatment cascade at an urban postincarceration transitions clinic.
    Hawks L; Norton BL; Cunningham CO; Fox AD
    J Viral Hepat; 2016 Jun; 23(6):473-8. PubMed ID: 26856967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis C.
    Chirikov VV; Shaya FT; Mullins CD; dosReis S; Onukwugha E; Howell CD
    Expert Rev Gastroenterol Hepatol; 2015; 9(11):1447-62. PubMed ID: 26524244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach.
    Kamali I; Barnhart DA; Nyirahabihirwe F; de la Paix Gakuru J; Uwase M; Nizeyumuremyi E; Walker S; Mazimpaka C; de Dieu Gatete J; Makuza JD; Serumondo J; Kateera F; d'Amour Ndahimana J
    BMC Infect Dis; 2021 Feb; 21(1):220. PubMed ID: 33632165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland--using spontaneous resolvers as the benchmark comparator.
    Innes H; Hutchinson SJ; Obel N; Christensen PB; Aspinall EJ; Goldberg D; Krarup H; McDonald SA; McLeod A; Weir A; Omland LH
    Hepatology; 2016 May; 63(5):1506-16. PubMed ID: 26773546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience.
    Hutchinson SJ; Dillon JF; Fox R; McDonald SA; Innes HA; Weir A; McLeod A; Aspinall EJ; Palmateer NE; Taylor A; Munro A; Valerio H; Brown G; Goldberg DJ
    Int J Drug Policy; 2015 Nov; 26(11):1041-9. PubMed ID: 26123893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of a database of diagnosed HCV-infected persons in Scotland.
    Shaw L; Taylor A; Roy KM; Cameron SO; Burns S; Molyneaux P; McIntyre P; Codere G; Goldberg D
    Commun Dis Public Health; 2003 Dec; 6(4):305-10. PubMed ID: 15067856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of deferral of treatment for hepatitis C infection in Australian clinics.
    Gidding HF; Law MG; Amin J; Macdonald GA; Sasadeusz JJ; Jones TL; Strasser SI; George J; Dore GJ;
    Med J Aust; 2011 Apr; 194(8):398-402. PubMed ID: 21495939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Public health clinic-based hepatitis C testing and linkage to care in Baltimore.
    Falade-Nwulia O; Mehta SH; Lasola J; Latkin C; Niculescu A; O'Connor C; Chaulk P; Ghanem K; Page KR; Sulkowski MS; Thomas DL
    J Viral Hepat; 2016 May; 23(5):366-74. PubMed ID: 26840570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program.
    Trooskin SB; Poceta J; Towey CM; Yolken A; Rose JS; Luqman NL; Preston TW; Chan PA; Beckwith C; Feller SC; Lee H; Nunn AS
    J Gen Intern Med; 2015 Jul; 30(7):950-7. PubMed ID: 25680353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?
    Innes H; Goldberg D; Dillon J; Hutchinson SJ
    Gut; 2015 Nov; 64(11):1800-9. PubMed ID: 25378522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proper patient education improves hepatitis C patients' disease-related knowledge and antiviral treatment acceptance in rural China].
    Yang M; Rao HY; Feng B; Wu E; Wei L; Lok AS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):824-828. PubMed ID: 30616316
    [No Abstract]   [Full Text] [Related]  

  • 38. Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach.
    Giudici F; Bertisch B; Negro F; Stirnimann G; Müllhaupt B; Moradpour D; Cerny A; Keiser O;
    J Viral Hepat; 2016 Sep; 23(9):697-707. PubMed ID: 27006320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is travel-time to a specialist centre a risk factor for non-referral, non-attendance and loss to follow-up among patients with hepatitis C (HCV) infection?
    Astell-Burt T; Flowerdew R; Boyle P; Dillon J
    Soc Sci Med; 2012 Jul; 75(1):240-7. PubMed ID: 22516762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015.
    Halota W; Flisiak R; Boroń-Kaczmarska A; Juszczyk J; Pawłowska M; Simon K; Tomasiewicz K; Małkowski P;
    Przegl Epidemiol; 2015; 69(3):515-21, 625-31. PubMed ID: 26519849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.